@article{4bc3d08277ef451fb632a4db999c4114,
title = "Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies",
author = "Shashi Gujar and Pol, {Jonathan G.} and Youra Kim and Lee, {Patrick W.} and Guido Kroemer",
note = "Funding Information: S.G. and P.W.L. are supported by grants from the Canadian Institutes of Health Research (CIHR) , Terry Fox Research Institute (TFRI) , and Canadian Cancer Research Institute (CCSRI) . Y.K. is currently supported by the CIHR Doctoral Award. G.K.{\textquoteright}s team is supported by the French Ligue Contre le Cancer (equipe labellis{\'e}e); Agence Nationale de la Recherche (ANR) – Projets blancs; ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases; Association pour la recherche sur le cancer (ARC); Canc{\'e}rop{\^o}le {\^I}le-de-France; Institut National du Cancer (INCa); L{\textquoteright}Institut Universitaire de France; Fondation pour la Recherche M{\'e}dicale (FRM); the European Commission (ArtForce); the European Research Council (ERC); the Leducq Foundation; the LabEx Immuno-Oncology; the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); the SIRIC Cancer Research and Personalized Medicine (CARPEM); and the Paris Alliance of Cancer Research Institutes (PACRI). Publisher Copyright: {\textcopyright} 2017 Elsevier Ltd",
year = "2018",
month = mar,
doi = "10.1016/j.it.2017.11.006",
language = "English",
volume = "39",
pages = "209--221",
journal = "Trends in Immunology",
issn = "1471-4906",
publisher = "Elsevier Limited",
number = "3",
}
